НОВОСТИ .RU
НОВОСТИ .COM
- Ridesharing company YayYo sets terms of IPO to raise up to $11.3 million
- Abbott Laboratories sees Q3 adj. EPS 73 cents-75 cents; FactSet consensus 74 cents
- Abbott Laboratories raised 2018 adj. EPS outlook to $2.85-$2.91 from $2.80-$2.90
- Abbott Laboratories Q2 established pharma sales up 10.5% to $1.13 bln; FactSet consensus $1.14 bln
- Abbott Laboratories Q2 medical devices sales up 11.3% to $2.89 bln; FactSet consensus $2.82 bln
